Related Experiment Video
Updated: Mar 21, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
Isavuconazole as salvage therapy for mucormycosis
Bianca Graves1, C Orla Morrissey2, Andrew Wei3
1Department of Infectious Diseases, Alfred Hospital, Melbourne, Australia.
Abstract:
Mucormycosis carries a high mortality rate with few therapeutic options available. We describe a man with pulmonary/splenic mucormycosis complicating hypoplastic myelodysplastic syndrome on a background of chronic kidney disease, who achieved a complete response with salvage isavuconazole therapy following intolerance of consecutive courses of liposomal amphotericin and posaconazole therapy.
Related Concept Videos
Antifungal Agents
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Pharmaceutical Poisoning: Treatment Strategies
Drugs for Treatment of Ulcerative Colitis in IBD

